(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THE LYMPHATIC MALFORMATION INSTITUTE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

THE LYMPHATIC MALFORMATION INSTITUTE

ST13

US500000085286451

Class

36

Filing

85286451

Registration

4119779

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

09/08/2022

Trademark type

Word

Nice classes

36

Filing date

04/05/2011

Registration date

03/27/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/08/2022

Last transaction

09/08/2022

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

12/17/2010

First use in commerce

02/09/2011

Drawing code

4

Owner type

03

Owner location

Bethesda, MD

Examiner

BURNS, ELLEN

Law office

M70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

The Lymphatic Malformation Institute

Representatives

Miles P. Welo Turner Welo LLC

Technical classification

Nice Classes

Class 36

Vienna Codes

No Vienna codes available.

Goods and services

Class 36

Charitable servicesfunding scientific and medical research and studies by medical and research professionals that will advance the understanding of lymphatic malformation and the human lymphatic system as a whole

Publications

History of USPTO decisions and trademark events.

35 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/08/2022

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/08/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/08/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/08/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

03/16/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

03/27/2021

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

03/14/2018

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

03/14/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/14/2018

ES8R

TEAS SECTION 8 RECEIVED

02/22/2018

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/27/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/14/2014

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/17/2014

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

03/27/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/23/2012

ALIE

ASSIGNED TO LIE

02/22/2012

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

02/09/2012

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

02/08/2012

IUAA

USE AMENDMENT ACCEPTED

02/08/2012

XAEC

EXAMINER'S AMENDMENT ENTERED

02/08/2012

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/08/2012

GNEA

EXAMINERS AMENDMENT E-MAILED

02/08/2012

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/08/2012

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

02/02/2012

IUAF

USE AMENDMENT FILED

02/02/2012

EAAU

TEAS AMENDMENT OF USE RECEIVED

02/01/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/09/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/09/2012

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/09/2012

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/11/2011

GNRT

NON-FINAL ACTION E-MAILED

07/11/2011

CNRT

NON-FINAL ACTION WRITTEN

07/11/2011

DOCK

ASSIGNED TO EXAMINER

07/04/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/09/2011

NWAP

NEW APPLICATION ENTERED

04/08/2011

Continuous trademark protection

Get notified about every new filing that threatens THE LYMPHATIC MALFORMATION INSTITUTE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.